Midori Ishii

725 total citations
41 papers, 518 citations indexed

About

Midori Ishii is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Midori Ishii has authored 41 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 9 papers in Immunology. Recurrent topics in Midori Ishii's work include CAR-T cell therapy research (8 papers), Sarcoma Diagnosis and Treatment (7 papers) and Immune Cell Function and Interaction (5 papers). Midori Ishii is often cited by papers focused on CAR-T cell therapy research (8 papers), Sarcoma Diagnosis and Treatment (7 papers) and Immune Cell Function and Interaction (5 papers). Midori Ishii collaborates with scholars based in Japan, United States and India. Midori Ishii's co-authors include Yoshiyuki Suehara, Tsuyoshi Saito, Keisuke Akaike, Kazuo Kaneko, Kenta Mukaihara, Tatsuya Takagi, Taketo Okubo, Daisuke Kubota, Takashi Yao and Hiromitsu Nakauchi and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Midori Ishii

36 papers receiving 503 citations

Peers

Midori Ishii
Takakuni Tanizawa Japan
Anna J. Strachan Australia
Nicole Allen United States
YOSHIHARU KANAJI Pakistan
Koji Tsugawa Japan
Sarah E. Panzer United States
Samantha Milanesi Italy
Leonard A. Arbeit United States
Kristian L. Jones Australia
Nurşen Keleş Türkiye
Takakuni Tanizawa Japan
Midori Ishii
Citations per year, relative to Midori Ishii Midori Ishii (= 1×) peers Takakuni Tanizawa

Countries citing papers authored by Midori Ishii

Since Specialization
Citations

This map shows the geographic impact of Midori Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Midori Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Midori Ishii more than expected).

Fields of papers citing papers by Midori Ishii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Midori Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Midori Ishii. The network helps show where Midori Ishii may publish in the future.

Co-authorship network of co-authors of Midori Ishii

This figure shows the co-authorship network connecting the top 25 collaborators of Midori Ishii. A scholar is included among the top collaborators of Midori Ishii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Midori Ishii. Midori Ishii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ishii, Midori, Takaharu Kimura, Tomoyuki Yamaguchi, et al.. (2024). Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung Cancer. Cancer Research Communications. 4(3). 723–737. 7 indexed citations
3.
Ishii, Midori, et al.. (2023). iPSC-Derived CD4 T Cell Generation and Investigation of CD4/CD8 T Cell Lineage Choice. Blood. 142(Supplement 1). 2071–2071. 3 indexed citations
4.
Ishii, Midori, Jun Ando, Kazuya Ikeda, et al.. (2023). iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer. Cell Reports Medicine. 4(12). 101327–101327. 10 indexed citations
5.
Sato, Ai, et al.. (2023). Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis. Experimental Hematology. 130. 104132–104132. 1 indexed citations
6.
Yasuda, Hajime, Naoko Kaga, Hikari Taka, et al.. (2023). Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma. Cancer Chemotherapy and Pharmacology. 93(3). 265–268.
7.
Ishii, Midori, Jun Ando, Satoshi Yamazaki, et al.. (2021). iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma. Cancer Immunology Research. 9(10). 1175–1186. 17 indexed citations
8.
Ando, Jun, Midori Ishii, Yoichiro Mitsuishi, et al.. (2021). SCLC-J1, a novel small cell lung cancer cell line. Biochemistry and Biophysics Reports. 27. 101089–101089. 4 indexed citations
9.
Ando, Miki, Jun Ando, Midori Ishii, et al.. (2021). Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma. Molecular Therapy. 30(2). 534–549. 29 indexed citations
10.
Ando, Miki, Jun Ando, Midori Ishii, et al.. (2021). Trigenic ADH5/ALDH2/ADGRV1 mutations in myelodysplasia with Usher syndrome. Heliyon. 7(8). e07804–e07804. 3 indexed citations
11.
Ando, Miki, Jun Ando, Midori Ishii, et al.. (2020). Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers. Molecular Therapy. 28(11). 2394–2405. 21 indexed citations
12.
13.
Suehara, Yoshiyuki, Shuko Nojiri, Taketo Okubo, et al.. (2018). The Development of the Short-form of “25-Question Geriatric Locomotive Function Scale”. Journal of Advances in Medicine and Medical Research. 25(10). 1–13. 7 indexed citations
14.
Akaike, Keisuke, Midori Ishii, Tsuyoshi Saito, et al.. (2016). A case of secondary chondrosarcoma with TP53 mutation arising from fibrous dysplasia. International Journal of Clinical and Experimental Pathology. 9(7). 7230–7236.
15.
Mukaihara, Kenta, Yoshiyuki Suehara, Shinji Kohsaka, et al.. (2016). Expression of F-actin-capping protein subunit beta, CAPZB, is associated with cell growth and motility in epithelioid sarcoma. BMC Cancer. 16(1). 206–206. 14 indexed citations
16.
Ishii, Midori, Keisuke Akaike, Yoshiyuki Suehara, et al.. (2016). Clinicopathological effects of protein phosphatase 2, regulatory subunit A, alpha mutations in gastrointestinal stromal tumors. Modern Pathology. 29(11). 1424–1432. 16 indexed citations
17.
Takagi, Tatsuya, Hirohisa Katagiri, Yoshiyuki Suehara, et al.. (2015). Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases. PLoS ONE. 10(6). e0129428–e0129428. 39 indexed citations
18.
Saito, Tsuyoshi, Keisuke Akaike, Aiko Kurisaki‐Arakawa, et al.. (2015). TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients. Molecular and Clinical Oncology. 4(1). 61–64. 21 indexed citations
19.
Akaike, Keisuke, Midori Ishii, Yoshiyuki Suehara, et al.. (2015). TERT promoter mutations are a rare event in gastrointestinal stromal tumors. SpringerPlus. 4(1). 836–836. 5 indexed citations
20.
Manabe, H., Nobuhiro Oda, Midori Ishii, & Akira Ishii. (1991). The posterior inferior cerebellar artery originating from the internal carotid artery, associated with multiple aneurysms. Neuroradiology. 33(6). 513–515. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takakuni Tanizawa Breakdown of academic impact, for papers by Anna J. Strachan Breakdown of academic impact, for papers by Nicole Allen Breakdown of academic impact, for papers by YOSHIHARU KANAJI Breakdown of academic impact, for papers by Koji Tsugawa Breakdown of academic impact, for papers by Sarah E. Panzer Breakdown of academic impact, for papers by Samantha Milanesi Breakdown of academic impact, for papers by Leonard A. Arbeit Breakdown of academic impact, for papers by Kristian L. Jones Breakdown of academic impact, for papers by Nurşen Keleş
Rankless by CCL
2026